Published in J Exp Med on May 01, 1969
A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med (1971) 9.81
The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med (1974) 3.53
Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc Natl Acad Sci U S A (1971) 3.50
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides. J Exp Med (1974) 2.34
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci U S A (1974) 2.27
The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med (1970) 2.16
Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus. J Exp Med (1974) 2.12
Host-gene control of type-C RNA tumor virus expression and tumorigenesis in inbred mice. Proc Natl Acad Sci U S A (1973) 1.83
The pathogenesis of autoimmunity in New Zealand mice. 3. Factors influencing the formation of anti-nucleic acid antibodies. Immunology (1971) 1.68
Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections. Clin Exp Immunol (1970) 1.59
Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med (1970) 1.58
Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect Immun (1978) 1.53
Tissue localization of Australia antigen immune complexes in acute and chronic hepatitis and liver cirrhosis. Am J Pathol (1972) 1.51
The disease of the NZB mouse. Examination of exchange ovum transplantation derived NZB and CFW mice. Clin Exp Immunol (1972) 1.48
Chronic allogeneic disease. II. Development of lymphomas. J Exp Med (1970) 1.46
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Relative affinity of anti-protein antibodies in New Zealand mice. Clin Exp Immunol (1972) 1.39
Natural cytotoxic autoantibody against thymocytes in NZB mice. Clin Exp Immunol (1972) 1.34
Wild-type gross leukemia virus: classification of soluble antigens (GSA). J Virol (1972) 1.31
Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol (1971) 1.31
Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol (1974) 1.27
Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZBxNZW) F1 hybrid mice. Clin Exp Immunol (1970) 1.26
The genetic basis of autoimmunity in NZB mice studied by progeny-testing. Clin Exp Immunol (1971) 1.24
Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid mice. J Exp Med (1981) 1.17
Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice. Clin Exp Immunol (1972) 1.14
Inhibition of antigodies binding polyinosinic-polycytidylic acid in human and mouse lupus sera by viral and synthetic ribonucleic acids. J Clin Invest (1971) 1.10
The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects. Am J Pathol (1976) 1.09
Animal models of human systemic lupus erythematosus. Yale J Biol Med (1979) 1.02
Hyper-responsiveness in NZB mice to the experimental induction of anti-red cell autoantibody. Clin Exp Immunol (1977) 1.02
Demonstration of a genetic factor influencing spontaneous release of a xenotropic virus of mouse cells. Proc Natl Acad Sci U S A (1974) 1.02
Immunobiology of the autoantibody response. I. Circulating analogues of erythrocyte autoantigens and heterogeneity of the autoimmune response of NZB mice. Clin Exp Immunol (1973) 0.99
Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens. J Clin Invest (1978) 0.99
Detection of naturally occurring antibodies to RNA-dependent DNA polymerase of murine leukemia virus in kidney eluates of AKR mice. J Virol (1974) 0.96
Transmission of auto-immune haemolytic anaemia and murine leukaemia virus in NZB-BALB/c hybrid mice. Clin Exp Immunol (1976) 0.95
Quantitative studies of immunoglobulin deposition in the kidney, glomerular cell proliferation and glomerulosclerosis in NZB/NZW F1 hybrid mice. Clin Exp Immunol (1977) 0.94
Electron microscopic study of distinctive structures in peripheral blood lymphocytes obtained from twins with systemic lupus erythematosus. Am J Pathol (1975) 0.93
Failure to transfer haemolytic anaemia or glomerulonephritis with cell-free material from NZB mice. Clin Exp Immunol (1970) 0.90
Autoimmune New Zealand mouse. Alterations in C3 receptors, complement-induced clumps and follicular adherence of immune complexes. Immunology (1975) 0.90
Dissection of genetic mechanisms governing the expression of serum retroviral gp70 implicated in murine lupus nephritis. J Immunol (2008) 0.88
Spontaneous glomerulonephritis in the prosimian primate Galago. A correlative light, immunofluorescence and electron microscopic analysis. Am J Pathol (1970) 0.87
Type C RNA virus-specific antibody in human systemic lupus erythematosus demonstrated by enzymoimmunoassay. Proc Natl Acad Sci U S A (1978) 0.85
Immune complex diseases. I. Pathological changes in the kidneys of BALB-c mice neonatally infected with Moloney leukaemogenic and murine sarcoma viruses. Clin Exp Immunol (1971) 0.85
Immunological abnormalities in juvenile myelomonocytic leukaemia. Br Med J (1973) 0.84
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Monoclonal IgM surface immunoglobulin on lymphocytes of aging NZB mice and its induction in young mice by RNA. Clin Exp Immunol (1974) 0.83
Immunopathogenicity and oncogenicity of murine leukemia viruses. II. Infection of mice and rats with Scripps leukemia virus. Am J Pathol (1976) 0.82
Murine Type C viral envelope glycoprotein gp69/71 and lupus-like glomerulonephritis of New Zealand mice. An immunoperoxidase study. Am J Pathol (1977) 0.82
Prevention of spontaneous autoimmunity to DNA in NZB/Swiss mice by treatment with natural double-stranded RNA. Immunology (1975) 0.81
Suppression of antibodies to nucleic acids with polyinosinic-polycytidylic acid and cyclophosphamide in murine lupus. Clin Exp Immunol (1970) 0.79
Virus-associated immunopathology: animal models and implications for human disease. 1. Effects of viruses on the immune system, immune-complex diseases, and antibody-mediated immunologic injury. Bull World Health Organ (1972) 0.75
Malignant disease and the nephrotic syndrome. Br Med J (1971) 0.75
Immunopathology of nephritis in Africa. Bull World Health Organ (1972) 0.75
Association of interstitial nephritis with tubule cell injury and proliferation in NZB/NZW mice. Clin Exp Immunol (1978) 0.75
Renal disease in (NZB x NZW) F1 mice treated with antilymphocytic antibody. II. Effects of restoration with isogeneic, allogeneic, and xenogeneic lymphoid cells. Clin Exp Immunol (1970) 0.75
Electrocardiographic pattern in intracranial hemorrhage. Can Med Assoc J (1969) 0.75
Current views on the pathogenesis and etiology of rheumatoid arthritis. Can Med Assoc J (1969) 0.75
Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture. J Virol (1969) 9.39
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
Complement fixation and tissue culture assays for mouse leukemia viruses. Proc Natl Acad Sci U S A (1965) 7.77
Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45
The G (Gross) leukemia antigen. Cancer Res (1965) 6.07
A virus-induced rhabdomyosarcoma of mice. Natl Cancer Inst Monogr (1966) 5.61
Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses. Proc Natl Acad Sci U S A (1966) 5.34
Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature (1963) 4.66
THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS. Ann Intern Med (1963) 4.22
Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med (1966) 4.19
Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science (1967) 4.01
Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83
Spontaneous auto-immune disease in NZB/BL mice. Br J Haematol (1963) 3.53
The murine leukemia-sarcoma virus complex. Proc Natl Acad Sci U S A (1967) 3.24
Termination of acquired immunological tolerance to protein antigens following immunization with altered protein antigens. J Exp Med (1962) 3.00
Development and serial cellfree passage of a highly potent strain of mouse leukemia virus. Proc Soc Exp Biol Med (1957) 2.78
Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against gross lymphomas. Cancer Res (1962) 2.76
AUTOIMMUNE DISEASE IN NZB/BL MICE. I. PATHOLOGY AND PATHOGENESIS OF A MODEL SYSTEM OF SPONTANEOUS GLOMERULONEPHRITIS. J Exp Med (1965) 2.71
Occurrence of natural antibody to the G (gross) leukemia antigen in mice. Cancer Res (1966) 2.57
Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma. Blood (1966) 2.51
ANTINUCLEAR FACTOR IN MICE. J Immunol (1964) 2.48
Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice. Clin Exp Immunol (1968) 2.34
Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus. Virology (1968) 2.26
Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice. J Natl Cancer Inst (1968) 2.17
Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids. Int Rev Exp Pathol (1966) 2.01
AUTOANTIBODIES PRODUCED AGAINST MOUSE ERYTHROCYTES IN NZB MICE. Aust J Exp Biol Med Sci (1963) 1.96
Autoimmune reactions and virus-like particles in germ-free NZB mice. Lancet (1967) 1.88
GLOMERULONEPHRITIS AND LATE ONSET DISEASE OF MICE FOLLOWING NEONATAL VIRUS INFECTION. Nature (1964) 1.88
Autoimmune disease in mice. Ann N Y Acad Sci (1965) 1.85
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst (1968) 1.79
The effect of isoantibodies in vivo on three different transplantable neoplasms in mice. Cancer Res (1959) 1.64
Malignant changes in New Zealand black mice. Clin Exp Immunol (1967) 1.52
Particles resembling murine leukaemia virus in New Zealand black mice. Clin Exp Immunol (1968) 1.50
Immunological relationships of a filterable agent causing a leukemia in adult mice. I. The neutralization of infectivity by specific antiserum. J Exp Med (1959) 1.32
Autoimmune disease in NZB/BL mice. 3. Induction of membranous glomerulonephritis in young mice by the transplantation of spleen cells from old mice. J Exp Med (1966) 1.24
Wild-type Gross leukemia virus. 3. Serological tests as indicators of leukemia risk. J Natl Cancer Inst (1968) 1.16
[Presence of virus particles in organs of the NZB mouse]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.95
Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures. J Virol (1970) 11.14
Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture. J Virol (1969) 9.39
Complement fixation and tissue culture assays for mouse leukemia viruses. Proc Natl Acad Sci U S A (1965) 7.77
Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A (1969) 7.69
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
Report of an Outbreak of Q Fever at the National Institute of Health : II. Epidemiological Features. Am J Public Health Nations Health (1947) 7.39
Non-producer human cells induced by murine sarcoma virus. Int J Cancer (1975) 5.82
Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses. Proc Natl Acad Sci U S A (1966) 5.34
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet (1992) 5.14
Mechanochemical coupling in actomyosin energy transduction studied by in vitro movement assay. J Mol Biol (1990) 4.78
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes (2000) 4.55
A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc Natl Acad Sci U S A (1973) 4.55
Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med (1966) 4.19
Proteins of Rous sarcoma virus. Virology (1968) 3.84
Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci U S A (1982) 3.75
Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc Natl Acad Sci U S A (1970) 3.71
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59
The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med (1974) 3.53
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc Natl Acad Sci U S A (1971) 3.50
N.A.S. symposium: new evidence as the basis for increased efforts in cancer research. Proc Natl Acad Sci U S A (1972) 3.28
Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27
The murine leukemia-sarcoma virus complex. Proc Natl Acad Sci U S A (1967) 3.24
Experimental transmission of feline fibrosarcoma to cats and dogs. Nature (1970) 2.91
Shared viral antigen of mammalian leukaemia viruses. Nature (1970) 2.84
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction. J Cell Biol (1997) 2.82
C-type virus released from cultured human rhabdomyosarcoma cells. Nat New Biol (1972) 2.78
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res (1992) 2.72
Coexistence of intraspecies and interspecies specific antigenic determinants on the major structural polypeptide of mammalian C-type viruses. Nat New Biol (1971) 2.70
Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. J Exp Med (1968) 2.62
Occurrence of natural antibody to the G (gross) leukemia antigen in mice. Cancer Res (1966) 2.57
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Transformation of primary rat embryo cells by adenovirus type 2. Proc Natl Acad Sci U S A (1967) 2.53
Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice. J Exp Med (1967) 2.53
Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2. J Exp Med (1973) 2.52
Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma. Blood (1966) 2.51
Rescue of the genome of focus forming virus from rat non-productive lines by 5'-bromodeoxyruidine. Nat New Biol (1971) 2.51
Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg (2000) 2.49
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
In vitro isolation of stable rat sarcoma viruses. Proc Natl Acad Sci U S A (1978) 2.41
Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia. Virology (1978) 2.37
5-Bromo-2'-deoxyuridine potentiation of transformation of rat-embryo cells induced in vitro by 3-methylcholanthrene: induction of rat leukemia virus gs antigen in transformed cells. Proc Natl Acad Sci U S A (1973) 2.32
TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci U S A (1996) 2.31
Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J (2001) 2.23
Species-specific and interspecific antigenic determinants associated with the structural protein of feline C-type virus. Proc Natl Acad Sci U S A (1971) 2.20
Sequence analysis of the florfenicol resistance gene encoded in the transferable R-plasmid of a fish pathogen, Pasteurella piscicida. Microbiol Immunol (1996) 2.17
Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice. J Natl Cancer Inst (1968) 2.17
Construction of a human full-length cDNA bank. Gene (1994) 2.10
Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses. J Natl Cancer Inst (1969) 2.08
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene (1995) 2.05
Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids. Int Rev Exp Pathol (1966) 2.01
DNA polymerase activity associated with RNA tumor viruses. Proc Natl Acad Sci U S A (1970) 2.00
Recovery of a hamster-specific, focus-forming, and sarcomagenic virus from a "noninfectious" hamster tumor induced by the Kirsten Mouse sarcoma virus. J Natl Cancer Inst (1969) 2.00
THE REGENERATIVE CYCLE OF MOTONEURONS, WITH SPECIAL REFERENCE TO PHOSPHATASE ACTIVITY. J Exp Med (1945) 1.97
Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30. J Virol (1974) 1.95
Detection of resistance factors in fish pathogen Aeromonas liquefaciens. J Gen Microbiol (1971) 1.88
Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst (1968) 1.84
New visual markers of antibody for electron microscopy. Nature (1969) 1.83
Presence of avian tumor virus group-specific antigen in nonproducing Rous sarcoma cells of the chicken. Virology (1965) 1.81
Genetic control by the hr-locus of susceptibility and resistance to leukemia. Proc Natl Acad Sci U S A (1969) 1.80
Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res (1994) 1.80
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst (1968) 1.79
Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc Natl Acad Sci U S A (1999) 1.78
Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med (2000) 1.77
Evidence for the in vitro transfer of defective Rous sarcoma virus genome from hamster tumor cells to chick cells. Proc Natl Acad Sci U S A (1966) 1.76
Tumors induced in hamsters by a strain of adenovirus type 3: sharing of tumor antigens and "neoantigens" with those produced by adenovirus type 7 tumors. Proc Natl Acad Sci U S A (1965) 1.75
Chemical and immunological studies on mycobacterial polysaccharides. 1. Purification and properties of polysaccharides from human tubercle bacilli. J Bacteriol (1968) 1.74
Hamster-tropic sarcomagenic and nonsarcomagenic viruses derived from hamster tumors induced by the Gross pseudotype of Moloney sarcoma virus. Proc Natl Acad Sci U S A (1970) 1.71
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70
Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice. Int J Cancer (1972) 1.70
Adenovirus type 12-rat embryo transformation system. J Virol (1967) 1.67
Antibody responses in acute and chronic rubella. Proc Soc Exp Biol Med (1966) 1.66
Detection of cerebrospinal fluid leakage: initial experience with three-dimensional fast spin-echo magnetic resonance myelography. Acta Radiol (2008) 1.63
Detection of H-2 antigens on mouse spermatozoa by the cytotoxicity test. Nature (1970) 1.62
Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy. J Exp Med (1972) 1.62
Common cell surface antigen associated with mammalian C-type RNA viruses. Cell membrane-bound gs antigen. J Exp Med (1974) 1.61
A viral interference test for mouse leukemia viruses. Virology (1967) 1.60
[Relationship between chilliness of the limbs and daily-life conditions in young females]. Nihon Eiseigaku Zasshi (1995) 1.57
Cell surface antigens: serial sectioning of single cells as an approach to topographical analysis. Science (1971) 1.56
Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members. Proc Natl Acad Sci U S A (2001) 1.54
Presence of antigen common to avian tumor viral envelope antigen in normal chick embryo cells. Virology (1973) 1.54
Murine leukaemia virus group-specific antigen in the C-type virus-containing human cell line, ESP-1. Nature (1971) 1.53
Demonstration of two immunologically distinct xenotropic type C RNA viruses of mouse cells. Virology (1974) 1.52
Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest (1992) 1.52
Morphological transformation of rat embryo cells induced by diethylnitrosamine and murine leukemia viruses. J Natl Cancer Inst (1970) 1.50
Ulcerative colitis with skip lesions at the mouth of the appendix: a clinical study. Am J Gastroenterol (1998) 1.49
Nucleotide sequence analysis of the class G tetracycline resistance determinant from Vibrio anguillarum. Microbiol Immunol (1992) 1.48
Murine C-type RNA virus from spontaneous neoplasms: in vitro host range and oncogenic potential. Science (1973) 1.48
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha. J Biol Chem (1996) 1.45
Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res (1996) 1.45
Empyema and mediastinitis complicating retropharyngeal abscess. Thorax (1994) 1.45
Anbtibiotics and drug resistance in animals. R factors related to fish culturing. Ann N Y Acad Sci (1971) 1.44
Non-familial olivopontocerebellar atrophy combined with late onset Alzheimer's disease: a clinico-pathological case report. J Neurol Sci (1998) 1.44
Persistent abnormalities of the metabolism of an oral glucose load in insulin-treated type I diabetics. Metabolism (1989) 1.43
Studies of FBJ osteosarcoma virus in tissue culture. I. Biologic characteristics of the "C"-type viruses. J Natl Cancer Inst (1973) 1.43